Mirae Asset Global Investments Co., Ltd. Merus N.V. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Merus N.V. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,281 shares of MRUS stock, worth $107,412. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,281
Previous 2,467
7.54%
Holding current value
$107,412
Previous $123,000
22.76%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding MRUS
# of Institutions
202Shares Held
60.7MCall Options Held
111KPut Options Held
85.7K-
Rtw Investments, LP New York, NY4.17MShares$196 Million2.86% of portfolio
-
Commodore Capital LP New York, NY3.87MShares$182 Million16.32% of portfolio
-
Wellington Management Group LLP Boston, MA3.5MShares$165 Million0.03% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.97MShares$140 Million3.1% of portfolio
-
Samlyn Capital, LLC New York, NY2.67MShares$126 Million1.81% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $2.16B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...